ShockWave Medical, Inc.
ShockWave Medical, Inc. (SWAV) Stock Overview
Explore ShockWave Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12.6B
P/E Ratio
83.43
EPS (TTM)
$4.25
ROE
0.25%
SWAV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ShockWave Medical, Inc. (SWAV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $421.27.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 83.43 and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.